IFN-? stimulated dental follicle mesenchymal stem cells regulate activated lymphocyte response in rheumatoid arthritis patients in vitro
Open Access
- 1 January 2019
- journal article
- research article
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 49 (6) , 1779-1788
Abstract
Multipotent mesenchymal stem cells (MSCs) have been investigated in autoimmune diseases such as rheumatoid arthritis (RA) due to their immunomodulatory and regenerative properties. In this study, their immunosuppressive effects on peripheral blood mononuclear cells (PBMC) of RA patients were studied. Dental Follicle Stem Cells (DFSCs) were isolated from follicle tissue in the orofacial region. Characterization and multipotency analyses were performed. Lymphocytes were isolated from peripheral venous blood of RA patients (n=5) and healthy individuals (n=5). DFSCs were pre-incubated with IFN-? for 48 hr. PBMCs of RA patients and healthy individuals were separately cultured with or without DFSCs for 72 hours. After the culture period, lymphocyte proliferation and viability, the frequency of CD4+ CD25+FoxP3+ T regulatory cells, IL-10 and TNF-? levels in the culture supernatants were measured via flow cytometry. Our results demonstrated that DFSCs suppressed proliferation of T lymphocytes by increasing the number of FoxP3 expressing CD4+CD25+ T regulatory cells and suppressed lymphocyte apoptosis in RA patients. Also, DFSCs reduced TNF-? cytokine secretion and upregulated IL-10 secreting cells. Such cells could potentially be a source for future immunomodulatory treatments of RA patients.Keywords
This publication has 18 references indexed in Scilit:
- Treatment of rheumatoid arthritis with tumour necrosis factor inhibitorsBritish Journal of Pharmacology, 2011
- Treating rheumatoid arthritis to target: recommendations of an international task forceAnnals of the Rheumatic Diseases, 2010
- Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2010
- Regulatory T cells as therapeutic targets in rheumatoid arthritisNature Reviews Rheumatology, 2009
- Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric OxideCell Stem Cell, 2008
- Tumor necrosis factor as a therapeutic target of rheumatologic diseaseExpert Opinion on Therapeutic Targets, 2007
- Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen‐induced arthritisArthritis & Rheumatism, 2007
- Comparison of human stem cells derived from various mesenchymal tissues: Superiority of synovium as a cell sourceArthritis & Rheumatism, 2005
- Regulatory T-cell therapy: is it ready for the clinic?Nature Reviews Immunology, 2005
- Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα TherapyJournal of Experimental Medicine, 2004